Ethos Discovery acts as an incubator for Scientific Innovations addressing unmet diagnostic and therapeutic needs.

Ethos Discovery is a stand-alone not for profit created to fulfill unmet needs that hold the potential to improve outcomes for veterinary and human health care patients. It is our hope that Ethos Discovery research and clinical studies will pave the way for innovations that provide improved diagnostic and treatment options that lead to a cure for complex medical conditions such as cancer. Our scientific studies are aligned with the innovation platforms of a variety of academic and research institutions. We embrace the established scientific model of comparative oncology, and evaluate novel diagnostics and therapeutic treatments in pets with naturally-occurring medical conditions.

About Us
Donate

Donate

Help change the future for pets (and humans) with complex medical problems. 100% of your donation will go towards supporting our research.

Learn more & Donate Today
Our Programs

Our Programs

Our scientific strategy focuses on identifying areas of unmet need through the optics of clinical teams within Ethos Veterinary Health. These hospitals provide us with access to families with pets with naturally occurring disease.

Our Studies
Study Guides

Study Guides

When you enroll your pet in an Ethos Discovery study your pet continues to receive therapy for his or her condition under the care of your existing specialist. More information and relevant details are available for study participants.

What to Expect
Our Team

Our Team

The leadership team at Ethos Discovery aligns the identified, unmet needs of clinical veterinary teams with academic and institutional nonprofit and commercial collaborators around the world.

Leadership Team
Ethos Hospitals

Ethos Hospitals

Ethos is a veterinary health organization with hospitals across the U.S. providing advanced medical care for pets. This real-time collaboration with Ethos clinicians allows us to develop new diagnostic and therapeutic solutions we can implement and share.

Ambassador Program

Latest Posts

View All

Latest News

LexaGene Finalizes Design of Pneumonia Panel

November 1, 2021

BEVERLY, Mass. USA – November 1, 2021 – LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary diagnostics, today announced it has finalized the design of the MiQLab™ Pneumonia Panel for companion animals and completed initial multiplex

Read Article

Join Our Email List